An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
End Stage Renal DiseaseInvestigators know that many patients who are on dialysis suffer from burden of unwanted symptoms, which can affect quality of life. The understanding and treatment of symptom burden by healthcare providers is limited and should be recognized as a high priority in the care of the dialysis population. In this study, the investigators will be assessing symptom burden using the London Evaluation of Illness "LEVIL," an application based platform where patients self-report their symptoms with one to three hemodialysis treatments per week for 28 weeks. The investigators would like to compare the currently available dialyzer with a new dialyzer that is capable of removing solutes of higher molecular weight that may or may not cause patients to experience symptoms related to increased amounts of toxins in their blood.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
* Conventional thrice weekly HD schedule
* Must be on chronic hemodialysis for at least 3 months
* Age ≥18 years
* Willing and able to give informed consent
Exclusion Criteria:
* Active infection (may enroll once infection is cleared)
* Patients receiving daily hemodialysis treatment
* Patients currently receiving Hemodiafiltration (HDF), Hemofiltration (HF) or Isolated ultrafiltration (ISO UF) more than once in three months
* Visual impairment
* History of neurocognitive impairment
* History of stroke (CVA)
Study Location
Victoria Hospital, London Health Sciences Centre
Victoria Hospital, London Health Sciences CentreLondon, Ontario
Canada
Contact Study Team
Westmount Kidney Care Centre
Westmount Kidney Care CentreLondon, Ontario
Canada
Contact Study Team
- Study Sponsored By
- London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
- Participants Required
- More Information
- Study ID:
NCT06032208